Navigation Links
Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming
Date:12/12/2008

WASHINGTON, Dec. 12 /PRNewswire-USNewswire/ -- Laura Rogers, project director for the Pew Campaign on Human Health and Industrial Farming, today issued the following statement regarding the U.S. Food and Drug Administration's decision to reverse its plan to ban off-label usage of certain antibiotics in animal agriculture:

"The misuse of antibiotics in animal agriculture helps fuel the increase in antibiotic-resistant infections - a fact long acknowledged by the American Medical Association, U.S. Centers for Disease Control and Prevention and even the FDA. Yet in another set-back for public health, the FDA reversed itself on the off-label use of cephalosporin - a family of antibiotics vitally important in human medicine - allowing this unrestricted use in industrial farm animal production to continue.

"Earlier this year, the agency had announced plans to ban all off-label uses in agriculture of these critical human drugs. Regrettably, the FDA changed its course.

"These important drugs are the only effective therapies for serious gastrointestinal diseases in children and also the best treatment for antibiotic-resistant infections in cancer patients. Easing restrictions on the use of cephalosporin on factory farms jeopardizes the effectiveness of these drugs and needlessly imperils our public health.

"In addition, the overuse of human antibiotics in farm animals is driving up the cost of healthcare. For example, in 1998 the Institute of Medicine estimated that antibiotic-resistant bacteria generated an estimated $4 billion to $5 billion per year in extra costs to the U.S. healthcare system.

"The incoming Administration and the new head of the FDA need to examine the overuse of antibiotics on factory farms. They must take the advice of the doctors and other public health professionals who have raised the alarm about antibiotic misuse and put the health of people - particularly susceptible groups like the elderly and children - ahead of industry profits. Change cannot come soon enough."

    For more information contact:
    Dan Klotz, 202-887-8855


'/>"/>
SOURCE Pew Charitable Trusts
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will ... Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in the ... beyond the standard of care, demonstrating leadership within the MPN community and/or a commitment ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... 2016 , ... The annual time frame to change Medicare health and prescription ... December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan ... to make changes during this period order for their new policy to go into ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain ... an injury, patients must find the one that works for them. When an inventor ... a machine that worked and decided to share it with others. , He developed ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical ... bekannt gegeben, ab diesem Monat seinen  INSTI HIV-Selbsttests  in einer Version mit ... ... New: INSTI Self Test! ... , ,      (Photo: ...
(Date:12/2/2016)... The iShares Nasdaq Biotechnology Exchange-Traded Fund ... victory early in November. Less political risk has boosted ... predicting an uptick in M&A activities. Today, Stock-Callers.com takes ... they have fared at the last close: Celldex Therapeutics ... (NASDAQ: FOLD ), Navidea Biopharmaceuticals Inc. (NYSE ...
(Date:11/30/2016)... Nov 30, 2016 Research and ... Overview for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - ... ... The full report suite on the U.S. market ... drainage systems, intracranial pressure monitoring devices, detachable coils, liquid embolics, ...
Breaking Medicine Technology: